Soluble, high-affinity dimers of T-cell receptors and class II major histocompatibility complexes: Biochemical probes for analysis and modulation of immune responses

被引:40
|
作者
Lebowitz, MS
O'Herrin, SM
Hamad, ARA
Fahmy, T
Marguet, D
Barnes, NC
Pardoll, D
Bieler, JG
Schneck, JP
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21205 USA
关键词
D O I
10.1006/cimm.1999.1441
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
T cell receptors (TCR) and major histocompatibility complex (MHC) molecules are integral membrane proteins that have central roles in cell-mediated immune recognition. Therefore, soluble analogs of these molecules would be useful for analyzing and possibly modulating antigen-specific immune responses. However, due to the intrinsic low-affinity and inherent solubility problems, it has been difficult to produce soluble high-affinity analogs of TCR and class II MHC molecules. This report describes a general approach which solves this intrinsic low-affinity by constructing soluble divalent analogs using IgG as a molecular scaffold. The divalent nature of the complexes increases the avidity of the chimeric molecules for cognate ligands. The generality of this approach was studied by making soluble divalent analogs of two different classes of proteins, a TCR (2C TCR(2)Ig) and a class II MHC (I-MCC. E-k (2)Ig) molecule, Direct flow cytometry assays demonstrate that the divalent 2C TCR(2)Ig chimera retained the specificity of the native 2C TCR, while displaying increased avidity for cognate peptide/MHC ligands, resulting in a high-affinity probe capable of detecting interactions that heretofore have only been detected using surface plasmon resonance. TCR(2)IgG was also used in immunofluorescence studies to show ER localization of intracellular peptide-MHC complexes after peptide feeding. I-MCC-E-k (2)Ig chimeras were able to both stain and activate an MCC-specific T cell hybridoma. Construction and expression of these two diverse heterodimers demonstrate the generality of this approach. Furthermore, the increased avidity of these soluble divalent proteins makes these chimeric molecules potentially useful in clinical settings for probing and modulating In vivo cellular responses. (C) 1999 Academic Press.
引用
收藏
页码:175 / 184
页数:10
相关论文
共 44 条
  • [1] Soluble, High-Affinity T-cell Receptors as Cancer Therapeutics
    Ashfield, Rebecca
    Adams, Katherine
    Bossi, Giovanna
    Williams, Daniel
    Dennis, Rebecca
    Paston, Samantha
    Harper, Jane
    Hassan, Namir
    McCormack, Emmet
    Iakobsen, Bent
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 1002 - 1002
  • [2] Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors
    OHerrin, SM
    Lebowitz, MS
    Bieler, JG
    alRamadi, BK
    Utz, U
    Bothwell, ALM
    Schneck, JP
    JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (08): : 1333 - 1345
  • [3] Making high-affinity T-cell receptors: A new class of targeted therapeutics
    Ashfield, Rebecca
    Jakobsen, Bent K.
    IDRUGS, 2006, 9 (08) : 554 - 559
  • [4] Localization of soluble major histocompatibility class II-peptide complexes on T cell surface
    Arimilli, S
    Deshpande, S
    Nag, B
    MICROSCOPY RESEARCH AND TECHNIQUE, 2000, 50 (05) : 419 - 424
  • [5] Generation of ImmTACTM molecules: Engineering high-affinity soluble T-cell receptors for the treatment of cancer
    Bombik, Izabela
    Bortoluzzi, Alessio
    Mai, Nicole
    Preston, Andrew
    Vuidepot, Annelise
    Jakobsen, Bent K.
    Liddy, Nathaniel
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [6] HIGH-AFFINITY REACTIONS BETWEEN ANTIGEN-SPECIFIC T-CELL RECEPTORS AND PEPTIDES ASSOCIATED WITH ALLOGENEIC AND SYNGENEIC MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I PROTEINS
    SYKULEV, Y
    BRUNMARK, A
    TSOMIDES, TJ
    KAGEYAMA, S
    JACKSON, M
    PETERSON, PA
    EISEN, HN
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) : 11487 - 11491
  • [7] HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II-RESTRICTED T-CELL RESPONSES IN TRANSGENIC MICE
    WOODS, A
    CHEN, HY
    TRUMBAUER, ME
    SIROTINA, A
    CUMMINGS, R
    ZALLER, DM
    JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01): : 173 - 181
  • [8] MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II ASSOCIATION AND INDUCTION OF T-CELL RESPONSES BY CARBOHYDRATES AND GLYCOPEPTIDES
    ISHIOKA, GY
    LAMONT, AG
    THOMSON, D
    BULBOW, N
    GAETA, FCA
    SETTE, A
    GREY, HM
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1993, 15 (2-3): : 293 - 302
  • [9] T-CELL RECOGNITION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II COMPLEXES WITH INVARIANT CHAIN PROCESSING INTERMEDIATES
    MORKOWSKI, S
    GOLDRATH, AW
    EASTMAN, S
    RAMACHANDRA, L
    FREED, DC
    WHITELEY, P
    RUDENSKY, AY
    JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05): : 1403 - 1413
  • [10] Reversed T-cell receptor docking on Major Histocompatibility Class I complexes within the naive T-cell repertoire limits involvement in the immune response
    Gras, S.
    Chadderton, J.
    Del Campo, C. M.
    Farenc, C.
    Wiede, F.
    Josephs, T. M.
    Mirams, M.
    Sng, X. Y. X.
    Watson, K.
    Tiganis, T.
    Quinn, K. M.
    Rossjohn, J.
    La Gruta, N. L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 525 - 525